Harvard Bioscience, Inc. (HBIO)
8.46
-0.10
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
8.46
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience EPS Diluted (Quarterly) : -0.643 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.643 |
| March 31, 2026 | -0.7655 |
| December 31, 2025 | -0.6383 |
| September 30, 2025 | -0.2763 |
| June 30, 2025 | -0.5151 |
| March 31, 2025 | -1.142 |
| December 31, 2024 | 0.004 |
| September 30, 2024 | -0.1101 |
| June 30, 2024 | -0.0673 |
| March 31, 2024 | -0.1082 |
| December 31, 2023 | -0.0426 |
| September 30, 2023 | -0.029 |
| June 30, 2023 | -0.0231 |
| March 31, 2023 | 0.0145 |
| December 31, 2022 | -0.0396 |
| September 30, 2022 | -0.0818 |
| June 30, 2022 | 0.0572 |
| March 31, 2022 | -0.1669 |
| December 31, 2021 | 0.0222 |
| September 30, 2021 | -0.0042 |
| June 30, 2021 | -0.0102 |
| March 31, 2021 | -0.0168 |
| December 31, 2020 | -0.0158 |
| September 30, 2020 | -0.0282 |
| June 30, 2020 | -0.0411 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1178 |
| December 31, 2019 | 0.0141 |
| September 30, 2019 | -0.0689 |
| June 30, 2019 | -0.0066 |
| March 31, 2019 | -0.063 |
| December 31, 2018 | 0.0612 |
| September 30, 2018 | -0.0069 |
| June 30, 2018 | -0.0412 |
| March 31, 2018 | -0.1492 |
| December 31, 2017 | 0.2853 |
| September 30, 2017 | -0.1197 |
| June 30, 2017 | -0.10 |
| March 31, 2017 | -0.3083 |
| December 31, 2016 | -0.04 |
| September 30, 2016 | -0.05 |
| June 30, 2016 | -0.02 |
| March 31, 2016 | -0.02 |
| December 31, 2015 | -0.5049 |
| September 30, 2015 | -0.02 |
| June 30, 2015 | 0.01 |
| March 31, 2015 | -0.04 |
| December 31, 2014 | -0.0006 |
| September 30, 2014 | 0.02 |
| June 30, 2014 | 0.03 |
| March 31, 2014 | 0.02 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Illumina, Inc. | 1.353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.91M |
| Revenue (Quarterly) | 22.73M |
| Total Expenses (Quarterly) | 25.64M |
| Enterprise Value | 76.67M |
| Gross Profit Margin (Quarterly) | 51.96% |
| Profit Margin (Quarterly) | -12.80% |
| Earnings Yield | -27.46% |
| Operating Earnings Yield | 1.51% |
| Normalized Earnings Yield | -25.95 |